BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33876838)

  • 1. Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
    Cipollari S; Jamshidi N; Du L; Sung K; Huang D; Margolis DJ; Huang J; Reiter RE; Kuo MD
    Prostate; 2021 Jun; 81(9):521-529. PubMed ID: 33876838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.
    Gold SA; VanderWeele DJ; Harmon S; Bloom JB; Karzai F; Hale GR; Marhamati S; Rayn KN; Mehralivand S; Merino MJ; Gulley JL; Bilusic M; Madan RA; Choyke PL; Turkbey B; Dahut W; Pinto PA
    Urol Oncol; 2019 Jun; 37(6):352.e25-352.e30. PubMed ID: 31000430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
    BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented-reality robot-assisted radical prostatectomy using hyper-accuracy three-dimensional reconstruction (HA3D™) technology: a radiological and pathological study.
    Porpiglia F; Checcucci E; Amparore D; Autorino R; Piana A; Bellin A; Piazzolla P; Massa F; Bollito E; Gned D; De Pascale A; Fiori C
    BJU Int; 2019 May; 123(5):834-845. PubMed ID: 30246936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.
    Maas MC; Litjens GJS; Wright AJ; Attenberger UI; Haider MA; Helbich TH; Kiefer B; Macura KJ; Margolis DJA; Padhani AR; Selnæs KM; Villeirs GM; Fütterer JJ; Scheenen TWJ
    Invest Radiol; 2019 Jul; 54(7):437-447. PubMed ID: 30946180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional microscopic analysis of clinical prostate specimens.
    van Royen ME; Verhoef EI; Kweldam CF; van Cappellen WA; Kremers GJ; Houtsmuller AB; van Leenders GJ
    Histopathology; 2016 Dec; 69(6):985-992. PubMed ID: 27353346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods.
    Lloyd-Lewis B; Davis FM; Harris OB; Hitchcock JR; Lourenco FC; Pasche M; Watson CJ
    Breast Cancer Res; 2016 Dec; 18(1):127. PubMed ID: 27964754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
    Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
    Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and localisation of primary prostate cancer using
    Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
    BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
    Ito K; Furuta A; Kido A; Teramoto Y; Akamatsu S; Terada N; Yamasaki T; Inoue T; Ogawa O; Kobayashi T
    Int J Clin Oncol; 2020 Apr; 25(4):732-740. PubMed ID: 31792635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobic and Hydrogel-Based Methods for Passive Tissue Clearing.
    Jalufka FL; Min SW; Platt ME; Pritchard AL; Margo TE; Vernino AO; Kirchhoff MA; Massopust RT; McCreedy DA
    Methods Mol Biol; 2022; 2440():197-209. PubMed ID: 35218541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?
    Jansen BHE; Nieuwenhuijzen JA; Oprea-Lager DE; Yska MJ; Lont AP; van Moorselaar RJA; Vis AN
    Urol Oncol; 2019 Mar; 37(3):181.e1-181.e6. PubMed ID: 30558983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications.
    Yaxley WJ; Nouhaud FX; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):398-405. PubMed ID: 32999464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.
    Fedorov A; Penzkofer T; Hirsch MS; Flood TA; Vangel MG; Masry P; Tempany CM; Mulkern RV; Fennessy FM
    Acad Radiol; 2015 May; 22(5):548-55. PubMed ID: 25683501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation.
    Al Salmi I; Menezes T; El-Khodary M; Monteiro S; Haider EA; Alabousi A
    Can J Urol; 2020 Jun; 27(3):10220-10227. PubMed ID: 32544044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.